Last update :
19/09/2022
References   References 4700  
Type : Manufacturer

Research teams :
Authors :
Title : Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics
Reference : AS Kalceks 2022

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionAmobarbital sodium General anesthetic
Incompatible + InjectionEsketamine
InjectionDiazepam Anxiolytic
Incompatible + InjectionEsketamine
InjectionDoxapram hydrochloride Respiratory stimulant
Incompatible + InjectionEsketamine
InjectionEsketamine General anesthetic
Factors which affect stability Temperature 4°C Induces Reduced stability
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 & 2 mg/ml 25°C Not specified
48 Hour
Stability in solutions Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 1 & 2 mg/ml 25°C Not specified
48 Hour
Incompatible + InjectionAmobarbital sodium
Incompatible + InjectionDiazepam
Incompatible + InjectionDoxapram hydrochloride
Incompatible + InjectionMethohexital sodium
Incompatible + InjectionPentobarbital sodium
Incompatible + InjectionPhenobarbital sodium
Incompatible + InjectionThiopental sodium
InjectionMethohexital sodium General anesthetic
Incompatible + InjectionEsketamine
InjectionPentobarbital sodium General anesthetic
Incompatible + InjectionEsketamine
InjectionPhenobarbital sodium Antiepileptic
Incompatible + InjectionEsketamine
InjectionThiopental sodium General anesthetic
Incompatible + InjectionEsketamine

  Mentions Légales